Wai Yuen Tong Medicine Holdings (HKSE:00897) Equity-to-Asset : 0.34 (As of Sep. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Wai Yuen Tong Medicine Holdings's Total Stockholders Equity for the quarter that ended in Sep. 2023 was HK$2,226 Mil. Wai Yuen Tong Medicine Holdings's Total Assets for the quarter that ended in Sep. 2023 was HK$6,584 Mil. Therefore, Wai Yuen Tong Medicine Holdings's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.34.

The historical rank and industry rank for Wai Yuen Tong Medicine Holdings's Equity-to-Asset or its related term are showing as below:

HKSE:00897' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.29 Med: 0.7 Max: 0.78
Current: 0.34

During the past 13 years, the highest Equity to Asset Ratio of Wai Yuen Tong Medicine Holdings was 0.78. The lowest was 0.29. And the median was 0.70.

HKSE:00897's Equity-to-Asset is ranked worse than
77.07% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs HKSE:00897: 0.34

Wai Yuen Tong Medicine Holdings Equity-to-Asset Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Equity-to-Asset Chart

Wai Yuen Tong Medicine Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Equity-to-Asset

Get a 7-Day Free Trial

0.71

0.34

0.32

0.33

0.34

Wai Yuen Tong Medicine Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Equity-to-Asset	Get a 7-Day Free Trial															0.33	0.33	0.33	0.34	0.34

Competitive Comparison of Wai Yuen Tong Medicine Holdings's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wai Yuen Tong Medicine Holdings's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's Equity-to-Asset falls into.

Wai Yuen Tong Medicine Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Wai Yuen Tong Medicine Holdings's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2349.191	/	7013.815
	=	0.33

Wai Yuen Tong Medicine Holdings's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2225.827	/	6583.962
	=	0.34

Wai Yuen Tong Medicine Holdings (HKSE:00897) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Wai Yuen Tong Medicine Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Equity-to-Asset

Traded in Other Exchanges

N/A

Address

39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG

Website

https://www.wyth.net

Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.

Executives

Wang On Group Limited	2501 Other
Tang Ching Ho	2501 Other
Yau Yuk Yin	2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines